MSB 3.33% $1.40 mesoblast limited

Cell Therapy News/Articles, page-63

  1. 6,124 Posts.
    lightbulb Created with Sketch. 1063
    THE BIGGER PICTURE

    The Japanese Government are strategically making moves to stay ahead of the game for Regenerative Medicine, recently signing MOU’s and aligning with Sector bodies and Countries. See links below.

    Positioning themselves as early movers!

    Japan and International Society for Cell Therapy

    http://www.celltherapysociety.org/news/369467/ISCT-announces-MoU-with-The-Forum-for-Innovative-Regenerative-Medicine-FIRM.htm\

    Japan and Ausbiotech

    https://www.ausbiotech.org/news/ausbiotech-aligns-with-japanese-industry-body

    * Silviu will be presenting at Ausbiotech National Conference 2017 this Wednesday 25th October as a keynote speaker at 9.50am in Adelaide

    http://ausbiotechnc.org/program-2/program

    Japan and India

    http://www.moneycontrol.com/news/in...esearch-on-regenerative-medicine-2357545.html

    Japan and UK

    https://www.epmmagazine.com/news/partnership-formed-for-regenerative-medicines/


    I expect increased activity in this space as the US and the EU are forced to play catch up.

    KEEP WATCH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.